The resolution of the expert council “Organization of care for patients with rheumatoid arthritis: regional characteristics, clinical standards, real clinical practice in the Ural and Siberian Federal Districts. The role of IL-6 in the pathogenesis of rhe

  • Елена Владимировна Зонова Novosibirsk State Medical University
  • Ольга Борисовна Несмеянова Chelyabinsk Regional Clinical Hospital
  • Инна Геннадьевна Банникова Surgut Regional Clinical Hospital
  • Ольга Викторовна Бугрова Orenburg State Medical University
  • Наталья Евгеньевна Григориади Perm Regional Clinical Hospital
  • Людмила Петровна Евстигнеева Sverdlovsk Regional Clinical Hospital
  • Алексей Николаевич Калягин Irkutsk State Medical University
  • Ирина Михайловна Патрикеева Regional Clinical Hospital No. 1, Tyumen
  • Павел Анатольевич Шестерня Krasnoyarsk State Medical University name Prof. V.F. Voyno-Yasenetsky

Abstract

On May 12, 2018, a meeting of the Scientific Council of Rheumatology Experts was held in Yekaterinburg to discuss the organization of care for patients with rheumatoid arthritis (RA): some aspects of the pathogenesis of RA, in particular the role of interleukin 6 (IL-6), new possibilities for suppressing pro-inflammatory mechanisms RA, regional features, clinical standards, real clinical practice in the Ural and Siberian Federal Districts. The Council of Experts includes scientific leaders in the field of rheumatology who have extensive experience in the use of genetic engineering biological therapy in patients with rheumatoid arthritis. The result of the work of the expert council was a resolution submitted to your attention.

References

1. Насонов Е.Л. Фармакотерапия ревматоидного артрита: Российские и Международные рекомендации. // Научно-практическая ревматология. 2016. Т. 54. №5. С. 557–571
2. Российские клинические рекомендации. Ревматология / под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа, 2017. 464 с.
3. Галушко Е.А., Эрдес Ш.Ф., Базоркина Д.И. и др. Распространенность ревматоидного артрита в России (по данным эпидемиологического исследования). // Терапевтический архив. 2010. Т. 82. №5. С. 9-14
4. Попков Т.В., Новиков Д.С., Насонов Е.Л. Интерлейкин 6 и сердечно-сосудистая патология при ревматоидном артрите. // Научно-практическая ревматология. 2011. №4. С. 64-72.

REFERENCES
1. Nasonov E.L. Pharmacotherapy of rheumatoid arthritis: Russian and International recommendations. // Scientific and practical rheumatology. 2016. V. 54. №5. P. 557–571. (in Russian)
2. Russian clinical guidelines. Rheumatology / Ed. E.L. Nasonov. Moscow: GEOTAR-Media, 2017. 464 p. (in Russian)
3. Galushko E.A., Erdes S.F., Bazorkina D.I., et al. The prevalence of rheumatoid arthritis in Russia (according to epidemiological studies). // Terapevticheskiy arkhiv. 2010. Vol. 82. №5. P. 9-14. (in Russian)
4. Popkov T.V., Novikov D.S., Nasonov E.L. Interleukin 6 and cardiovascular pathology in rheumatoid arthritis. // Scientific and practical rheumatology. 2011. №4. P. 64-72. (in Russian)
Published
2019-01-24
How to Cite
ЗОНОВА, Елена Владимировна et al. The resolution of the expert council “Organization of care for patients with rheumatoid arthritis: regional characteristics, clinical standards, real clinical practice in the Ural and Siberian Federal Districts. The role of IL-6 in the pathogenesis of rhe. Sibirskij Medicinskij Zurnal (Irkutsk) = Siberian Medical Journal (Irkutsk) 16+, [S.l.], v. 153, n. 2, p. 62-64, jan. 2019. ISSN 1815-7572. Available at: <http://smj.ismu.baikal.ru/index.php/osn/article/view/297>. Date accessed: 04 apr. 2025.
Section
Chronicle, information

Most read articles by the same author(s)

<< < 1 2 3